No takes yet. Share an insight, caveat, or question.
Review reveals NPM1 mutations enhance clonal evolution and genomic stability in acute myeloid leukemia, suggesting targeted therapies may improve outcomes.
Jiang et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: